Belinda Bagby
Psychiatric/Mental Health · Hutchinson, KSNPI 1083042956
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $34,100 of the $38,556 with a category attached, or 88.4%. AbbVie accounts for 95.5% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2023 at $18,142 and has fallen 87.1% since, to $2,340 in 2025. Among psychiatric/mental health clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 136 payments — averaging $283.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$37K
- Neurocrine Biosciences, Inc.$244
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$233
- Abbott$217
- Supernus Pharmaceuticals, Inc.$206
- Axsome Therapeutics, Inc.$160
- plus $680 from 12 others
What the payments were for
- Speaking & faculty fees$34,10088%
- Travel & lodging$2,0585%
- Food & beverage$2,3056%
- Education$940%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 78 | $36,815 |
| Neurocrine Biosciences, Inc. | 9 | $244 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $233 |
| Abbott | 2 | $217 |
| Supernus Pharmaceuticals, Inc. | 6 | $206 |
| Axsome Therapeutics, Inc. | 4 | $160 |
| Johnson & Johnson | 4 | $159 |
| E.r. Squibb & Sons, L.L.C. | 6 | $146 |
| Alkermes, Inc. | 4 | $113 |
| Novo Nordisk | 4 | $58 |
| Teva Pharmaceuticals USA, Inc. | 3 | $57 |
| Lundbeck LLC | 1 | $31 |
| Idorsia Pharmaceuticals US Inc | 2 | $29 |
| Vertex | 1 | $28 |
| Vanda Pharmaceuticals Inc. | 1 | $28 |
| Indivior Inc. | 1 | $16 |
| GSK | 1 | $14 |
| Genentech USA, Inc. | 1 | $1 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$38,556 in reported general payments places this provider in the 95th percentile of 404 psychiatric/mental health providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Austedo XrDeutetrabenazine | 58 | $413,425 |
| VraylarCariprazine Hcl | 200 | $301,655 |
| Lurasidone Hcl | 42 | $23,291 |
| BelsomraSuvorexant | 40 | $20,034 |
| RexultiBrexpiprazole | 12 | $16,946 |
| Aripiprazole | 168 | $13,578 |
| QelbreeViloxazine Hcl | 15 | $13,416 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 251 | $12,573 |
| QuviviqDaridorexant Hcl | 17 | $10,982 |
| TrintellixVortioxetine Hydrobromide | 18 | $8,964 |
| Hydroxyzine Hcl | 213 | $5,595 |
| Quetiapine Fumarate | 239 | $5,008 |
| Atomoxetine Hcl | 28 | $4,026 |
| Paliperidone ErPaliperidone | 19 | $2,846 |
| Duloxetine Hcl | 183 | $2,832 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo Xr | $57 | $413,42558 claims |
| AbbVieVraylar | $36,815 | $301,655200 claims |
| Supernus Pharmaceuticals, Inc.Qelbree | $206 | $13,41615 claims |
| Idorsia Pharmaceuticals US IncQuviviq | $29 | $10,98217 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 404 psychiatric/mental health providers in Kansas.
Other psychiatric/mental health in Hutchinson
- Marie Maugans ColemanHutchinson$8K
- Susan RuleHutchinson$6K
- Tina NortonHutchinson$4K
- Eric ThomasonPittsburg$333K
- Hayley KnappWichita$31K
- Jennifer KubinBaldwin City$26K
- Uyen DinhPittsburg$20K
- Louise MuhoziKansas City$14K
- Theresa MuellerOverland Park$14K
- Shiney ZchariaOlathe$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.